Amminger P. "Omega-3 Fatty Acids Reduce the Risk of Early Transition to Psychosis in Ultra-High Risk Individuals: A Double Blind Randomized Placebo Controlled Study," Schizophrenia Bulletin (2007): Vol. 33, Suppl., pp. 418–19.

Cannon TD, et al. "Prediction of Psychosis in Youth at High Clinical Risk: A Multisite Longitudinal Study in North America," Archives of General Psychiatry (Jan. 2008): Vol. 65, No. 1, pp. 28–37. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18180426

Cornblatt BA, et al. "Can Antidepressants be Used to Treat the Schizophrenia Prodrome? Results of a Prospective, Naturalistic Treatment Study of Adolescents," Journal of Clinical Psychiatry (April 2007): Vol. 68, No. 4, pp. 546–57. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17474810

Keshavan MS, et al. "Early Intervention in Schizophrenia: Current and Future Perspectives," Current Psychiatry Reports (Aug. 2007): Vol. 9, No. 4, pp. 325-28. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17880865

Koo MS, et al. "A Cross-Sectional and Longitudinal Magnetic Resonance Imaging Study of Cingulate Gyrus Gray Matter Volume Abnormalities in First-Episode Schizophrenia and First-Episode Affective Psychosis," Archives of General Psychiatry (July 2008): Vol. 65, No. 7, pp. 746–60. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18606948

Laurens KR, et al. "Community Screening for Psychotic-Like Experiences and Other Putative Antecedents of Schizophrenia in Children Aged 9-12 Years," Schizophrenia Research (Feb. 2007): Vol. 90, No. 1-3, pp. 130–46. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17207968

Marshall M, et al. "Early Intervention for Psychosis," Cochrane Database of Systematic Reviews (Oct. 18, 2006): Doc. No. CD004718. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17054213

McGlashan TH, et al. "Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis," American Journal of Psychiatry (May 2006): Vol. 163, No. 5, pp. 790–99. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16648318

McGorry PD, et al. "Intervention in Individuals at Ultra-High Risk for Psychosis: A Review and Future Directions," Journal of Clinical Psychiatry (Sept. 2009): Vol. 70, No. 9, pp. 1206–12. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19573499

McGorry PD, et al. "Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample with Subthreshold Symptoms," Archives of General Psychiatry (Oct. 2002): Vol. 59, No. 10, pp. 921–28. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12365879

Morrison AP, et al. "Cognitive Therapy for the Prevention of Psychosis in People at Ultra-High Risk: Randomised Controlled Trial," British Journal of Psychiatry (Oct. 2004): Vol. 185, No.4, pp. 291–97. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15458988

Nakamura M, et al. "Neocortical Gray Matter Volume in First-Episode Schizophrenia and First-Episode Affective Psychosis: A Cross-Sectional and Longitudinal MRI Study," Biological Psychiatry (Oct. 1, 2007): Vol. 62, No. 7, pp. 773–83. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17586477

Nordentoft M, et al. "Transition Rates from Schizotypal Disorder to Psychotic Disorder for First-Contact Patients Included in the OPUS Trial. A Randomized Clinical Trial of Integrated Treatment and Standard Treatment," Schizophrenia Research (March 2006): Vol. 83, No. 1, pp. 29–40. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16504481

Peet M. "Omega-3 Polyunsaturated Fatty Acids in the Treatment of Schizophrenia," Israeli Journal of Psychiatry and Related Science (2008): Vol. 45, No. 1, pp. 19–25. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18587166

Phillips LJ, et al. "Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Study Design and Baseline Characteristics," Australian and New Zealand Journal of Psychiatry (Sept. 2009): Vol. 43, No. 9, pp. 818–29. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19670055

Salisbury DF, et al. "Progressive and Interrelated Functional and Structural Evidence of Post-Onset Brain Reduction in Schizophrenia," Archives of General Psychiatry (May 2007): Vol. 64, No. 5, pp. 521–29. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17485604

Whitfield-Gabriel S, et al. "Hyperactivity and Hyperconnectivity in the Default Network in Schizophrenia and in First-Degree Relatives of Persons with Schizophrenia," Proceedings of the National Academy of Science of the U.S.A. (Jan. 27, 2009): Vol. 106, No. 4, pp. 1279–284.

Yoshida T, et al. "A Prospective Longitudinal Volumetric MRI Study of Superior Temporal Gyrus Gray Matter and Amygdala-Hippocampal Complex in Chronic Schizophrenia," Schizophrenia Research (Aug. 2009): Vol. 113, No. 1, pp. 84–94. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19524408

Yung AR, et al. "Association Between Psychotic Experiences and Depression in a Clinical Sample Over 6 Months," Schizophrenia Research (March 2007): Vol. 91, No. 1-3, pp. 246–53. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17239566